Treatment · July 16, 2026
FDA Approves First Daily Pill for High Cholesterol That Slashes LDL by 60 Percent
FDA approval of a new cholesterol pill expands treatment options for patients....
Treatment · July 16, 2026
FDA Approves New Daily Pill to Lower Bad Cholesterol Beyond Statins
A new cholesterol-fighting drug approval provides additional treatment options for patients....
Cancer · July 15, 2026
FDA Approves First Celcuity Drug for Advanced Breast Cancer
Celcuity's first FDA-approved breast cancer drug provides patients with an innovative new treatment option....
Cancer · July 15, 2026
FDA Nears Decision on Celcuity Breast Cancer Drug That Could Reshape Treatment
Promising breast cancer treatment receives FDA approval pathway consideration....
Pediatrics|Treatment|Breakthrough · July 13, 2026
FDA Accepts Application for Full Approval of Achondroplasia Drug Voxzogoe
FDA acceptance of BioMarin's supplemental application brings expanded treatment options for children with skeletal dysplasia....
Treatment · July 8, 2026
Two Boys With Rare Genetic Disorder Find Hope in New FDA-Approved Drug
Two boys with rare Hunter syndrome find hope and healing through a new FDA-approved treatment....
Treatment · June 30, 2026
FDA Approves Psoriasis Foam for Children as Young as Two
FDA approval of a new psoriasis treatment for children as young as 2 years old offers families a new therapeutic option for this c...
Treatment · June 30, 2026
FDA Approves New Thyroid Eye Disease Drug Offering Patients Another Option
Viridian has received FDA approval for Lumvoa, a new treatment offering patients additional therapeutic options....
Technology · June 27, 2026
FDA Proposes Voucher Program to Speed Review of Priority Drugs
FDA's new priority voucher program supports innovative drug development for critical needs....
Cancer · June 26, 2026
FDA Approves New Pill That Destroys Estrogen Receptors in Resistant Breast Cancer
Veppanu (vepdegestrant) receives FDA approval, offering breast cancer patients a new hormonal treatment option....
Treatment · June 25, 2026
New Drug to Repair Myelin Wins FDA Approval for Multiple Sclerosis Trials
FDA clears an investigational remyelinating agent for multiple sclerosis treatment....
Cancer · June 24, 2026
FDA Approves First Engineered T-Cell Therapy for Teens With Rare Sarcoma
FDA grants full approval for engineered cell therapy with expanded indication, helping more patients with blood cancers....
Cancer · June 22, 2026
FDA Decision Nears on Blood Test That Detects 50 Types of Cancer
A single blood test screening for multiple cancer types may soon become available, potentially revolutionizing early cancer detect...
Treatment · June 22, 2026
FDA Panel Backs Moderna’s mRNA Flu Vaccine for Older Adults
The FDA has approved Moderna's innovative mRNA-based flu vaccine, expanding protection against seasonal influenza....
Breakthrough · June 22, 2026
FDA Clears First Clinical Trial for New Multiple Sclerosis Remyelination Drug
Pheno Therapeutics' MS candidate receives FDA clearance to advance toward clinical trials, offering hope for multiple sclerosis pa...
Treatment · June 22, 2026
FDA Approves New Fly Species Maggots for Cleaning Chronic Wounds
A newly approved species of fly offers an innovative biological approach to wound healing and treatment....
Treatment · June 22, 2026
FDA and EMA Accept Regeneron Drug for Rare Muscle Disease Review
Regeneron's drug application for cemdisiran is accepted for FDA and EMA review, advancing treatment options for patients....
Treatment · June 18, 2026
FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
A new antibiotic treatment for complicated urinary tract infections has received FDA approval....
Treatment · June 13, 2026
FDA Approves Drug Combo to Lower Kidney Cancer Recurrence Risk After Surgery
FDA approves a new treatment option for kidney cancer patients at risk of recurrence....
Treatment · June 13, 2026
Experimental Pill for Rare Eye Disease Submitted for FDA Approval
Belite Bio advances toward FDA approval for an oral therapy treating Stargardt disease, a previously untreatable retinal condition...
Treatment · June 10, 2026
FDA Approves New Six Shots Per Year Eczema Maintenance Regimen
FDA approval of Ebglyss provides patients with a new eczema treatment option....
Technology · June 9, 2026
FDA Approves Trial of Minimally Invasive Ozone Injection for Herniated Discs
A minimally-invasive spinal treatment device received FDA approval to advance patient care options....
Breakthrough|Other · June 6, 2026
New Drug Approval Marks Major Shift in Precision Medicine Treatments
Medicine is experiencing a breakthrough moment with innovations transforming patient care....
Breakthrough|Cancer|Research · June 3, 2026
FDA Approves 10 Cancer Drugs in 2025 Based on Landmark Trials
Memorial Sloan Kettering-led research resulted in multiple new FDA-approved cancer drugs in 2025, advancing patient care....
Treatment|Cancer · June 3, 2026
FDA Approves New Oral Dissolving Drug for Chronic Myeloid Leukemia Patients
FDA approval of a new orally disintegrating tablet offers chronic myeloid leukemia patients greater flexibility in treatment optio...
Treatment · May 27, 2026
FDA Approves First Ever Treatment for Hepatitis D in the United States
FDA approves Hepcludex as the first-ever treatment for hepatitis D, offering hope to patients with limited options....
Treatment · May 26, 2026
FDA Approves New Ultrasound Treatment That Safely Breaks Kidney Stones
FDA approval of an innovative kidney stone treatment developed through biomedical engineering offers patients a new solution....
Cancer · May 26, 2026
FDA Approves Two New Treatments To Combat Ovarian Cancer
FDA approval of new ovarian cancer treatments expands therapeutic options for patients....
Treatment · May 25, 2026
Sleep Apnea Pill Moves Closer to Approval After Successful Late-Stage Trial
A novel nightly pill for sleep apnea has shown strong trial results and is being fast-tracked toward FDA approval....
Treatment · May 25, 2026
FDA Approves First Weekly Basal Insulin for Type 2 Diabetes
First-ever weekly basal insulin approved by FDA simplifies diabetes management for patients....
Treatment · May 21, 2026
Five First in Class Drug Approvals in 2026 Mark New Era in Medicine
Five FDA first-in-class drug approvals in 2026 bring innovative new treatment mechanisms to patients....
Treatment · May 19, 2026
New Blood Pressure Drug Targets Root Cause of Hypertension for First Time
FDA approves a new blood pressure medication providing patients with an additional hypertension management option....
Treatment · May 18, 2026
New Hypertension Drug Targets Hormone to Lower Stubbornly High Blood Pressure
FDA approval of the first aldosterone synthase inhibitor provides a new treatment option for hypertension patients....
Treatment · May 18, 2026
FDA Approves AstraZeneca Blood Pressure Drug for Resistant Hypertension
AstraZeneca's blood pressure drug receives US approval, offering patients another treatment option....
Cancer · May 14, 2026
FDA Approves Two New Drug Regimens for Hard to Treat Blood Cancers
FDA approvals of Beqalzi and Inqovi represent important new treatment options for patients with mantle cell lymphoma and blood can...
Cancer · May 14, 2026
FDA Approves First BCL2 Inhibitor for Tough-to-Treat Mantle Cell Lymphoma
BeOne receives FDA approval for a new mantle cell lymphoma therapy, establishing an entirely new class of treatment options for pa...
Treatment · May 14, 2026
Personalized Medicines Now Account for Over One Third of New Drug Approvals
FDA advances personalized, patient-centered care approaches offering more tailored treatment options....
Treatment · May 13, 2026
FDA Approves First Non-Antipsychotic Drug for Agitation in Alzheimer’s
FDA approval expands treatment options available to Alzheimer's disease patients....
Breakthrough · May 12, 2026
CRISPR Therapy for Rare Swelling Disorder Shows Promise in Key Trial
First in-body CRISPR gene therapy shows clinical success and moves toward FDA approval, representing a major breakthrough in genet...
Technology · May 12, 2026
FDA Approves First Drug From Protein Degrader Technology for Breast Cancer
A biotech company's first FDA-approved drug represents progress in bringing new treatments to market....
Pediatrics · May 11, 2026
FDA Approves Ocrevus for Children With Relapsing-Remitting Multiple Sclerosis
FDA approves Ocrevus for children with multiple sclerosis, expanding treatment options....
Cancer · May 9, 2026
First Protein Degradation Drug Wins FDA Approval for Advanced Breast Cancer
Yale-developed technology receives FDA approval, offering new hope for breast cancer patients....
Breakthrough · May 4, 2026
FDA Approves First New Schizophrenia Drug in Over 30 Years
Long-awaited medical breakthrough finally reaches patients after decades of research....
Treatment · May 1, 2026
FDA Approves First Pill That Degrades Cancer Proteins in Breast Cancer Advance
FDA approves VEPPANU as an innovative new treatment option for patients....
Treatment · April 30, 2026
Gene Therapy Implant Offers New Hope for Rare Eye Disease Patients
First-in-state surgery successfully treats rare retinal disease using newly approved FDA therapy....
Breakthrough · April 24, 2026
FDA Approves First Gene Therapy to Restore Hearing in Children Born Deaf
The FDA has approved the first gene therapy for genetic deafness, opening new possibilities for hearing restoration....
Pediatrics · April 23, 2026
First Patients Receive Newly Approved Therapy for Rare Childhood Disease
A child with rare genetic disease receives newly approved FDA treatment, offering hope for similar patients....
Treatment · April 21, 2026
FDA Approves New Long-Acting HIV Treatment for Drug-Resistant Patients
FDA approval of new HIV treatment provides patients with additional therapeutic options....
Treatment · April 21, 2026
FDA Approves New Two-Drug HIV Regimen for Adults With Suppressed Virus
FDA approval of once-daily HIV treatment pill offers patients improved convenience and care options....
Treatment · April 21, 2026
FDA Clears Investigational Drug for Chemotherapy Pain and Neuropathy
Dogwood Therapeutics receives FDA approval to advance its SP16 cancer program, moving closer to potential patient treatment....
Mental Health · April 20, 2026
Virginia Prepares for Medical Psilocybin Use Following Anticipated FDA Approval
New legislation advances FDA-approved psilocybin treatment option for patients in need....
Treatment · April 19, 2026
Four Novel Therapies Approach FDA Approval Offering New Hope for Chronic Conditions
Four promising new drugs entering treatment options this spring could significantly transform patient care across multiple conditi...
Mental Health · April 19, 2026
Federal Initiative Fast Tracks Psychedelic Therapies for Mental Health Conditions
Executive order expedites FDA review of psychedelics for treating mental health disorders....
Cancer · April 13, 2026
FDA Caps Year With Wave of New Cancer Drug Approvals and Expanded Options
Multiple new oncology drugs received FDA approval, expanding treatment options for cancer patients....
Cancer · April 13, 2026
FDA Clears First Cancer Drug for Human Trials Using Only Human Organoid Data
FDA approves new cancer drug for trials using innovative nonanimal data, marking progress in both treatment and ethical research....
Treatment · April 10, 2026
FDA Clears Novel Switchable CAR-T Therapy Trial for Major Autoimmune Diseases
FDA clears testing of innovative CAR-T therapy for autoimmune diseases, opening new therapeutic possibilities....
Mental Health · April 6, 2026
Bipartisan Bill Directs VA to Prepare for Future Psychedelic Therapies
New VA law prepares to implement FDA-approved psychedelic treatments for veterans....
Treatment · April 3, 2026
FDA Approves First Convenient Daily Pill for Weight Loss Without Meal Restrictions
FDA approval of a new oral GLP-1 pill offers patients another accessible weight loss treatment....
Treatment · April 1, 2026
FDA Approves New Daily Pill for Weight Management as Second Oral GLP-1 Option
Eli Lilly's new weight-loss pill receives FDA approval, offering patients an additional therapeutic option for obesity management....
Treatment · April 1, 2026
FDA Approves New Oral Weight Loss Drug Foundayo as Market Expands
FDA approval of Eli Lilly's GLP-1 pill provides patients with a new oral option for effective weight loss treatment....
Breakthrough · March 30, 2026
FDA Approves First Disease Modifying Therapy for Progressive Multiple Sclerosis
FDA made impactful decisions in neurology that advance patient treatment options....
Breakthrough · March 29, 2026
FDA Shifts Drug Approval Standard to Single Clinical Trial for Most New Medicines
FDA's removal of dual-study requirement expedites drug approvals and speeds life-saving treatments to patients....
Research · March 27, 2026
Drug Trial Success Rates Show Signs of Recovery After Decades of Decline
Analysis of clinical trial success rates in the 21st century provides insights for improving drug development and approval process...
Treatment · March 26, 2026
FDA Approves First Therapy for Ultra Rare Rapid Aging Disease Progeria
February FDA developments including kinase inhibitors, GLP-1 treatments, and new approval pathways represent important therapeutic...
Cancer · March 25, 2026
FDA Approves New Standard of Care for Head and Neck Cancer After Two Decades
FDA approvals in oncology during April-June 2025 bring new treatment options to cancer patients....
Treatment · March 25, 2026
FDA Approves Higher Dose Wegovy Offering Greater Average Weight Loss
New higher-dose Wegovy option gives patients more flexibility in managing their weight and health....
Treatment · March 25, 2026
US Health Authorities Continue Compassionate Access to Monkeypox Drug Tecovirimat
FDA-approved Tecovirimat provides an effective treatment option for monkeypox infections....
Breakthrough · March 24, 2026
FDA Approves First AI-Directed Cancer Therapy and Streamlines Drug Development Paths
FDA actions in 2026 are reshaping drug development to accelerate the pathway for new treatments to reach patients....
Cancer · March 23, 2026
New FDA Guidance Accelerates Myeloma Drug Approvals and Patient Access
Researchers achieve significant progress in developing new myeloma treatments....
Treatment · March 22, 2026
FDA Approves Higher-Dose Semaglutide for Weight Management Following Accelerated Review
Higher-dose semaglutide receives FDA approval through accelerated review, expanding treatment options....
Pediatrics · March 21, 2026
New Drug Awaits FDA Decision Offering Hope for Children With Fatal Hunter Syndrome
A mother's urgent advocacy for FDA approval of a new drug offers hope for children suffering from terminal Hunter Syndrome....
Technology · February 23, 2026
FDA Streamlines Approval Process to Accelerate Gene Therapy Access
FDA streamlines approval process for gene therapies, accelerating life-saving treatments to patients....
Treatment · February 23, 2026
FDA Unveils Plan To Speed Approval Of Rare Disease Treatments
FDA announces plans to accelerate approval timelines for rare disease treatments, benefiting patients in need....
Mental Health · February 20, 2026
FDA Approves New Drug for Bipolar Disorder and Schizophrenia
FDA approval of new bipolar disorder and schizophrenia treatment offers patients an additional therapeutic option....
Breakthrough · February 19, 2026
FDA To Allow Single-Study Drug Approvals In Bid To Speed New Treatments
FDA streamlines drug approval process with single-study requirement, potentially bringing life-saving treatments to patients faste...
Cancer · February 17, 2026
FDA Approves First New Treatment for Advanced Pancreatic Cancer in Years
The FDA has approved a new treatment option for patients with locally advanced pancreatic cancer, offering additional hope....
Cancer · January 2, 2026
FDA Approves Six Novel Cancer Therapies In Landmark Month For Oncology
Six new cancer therapies approved by FDA in December 2025, expanding hope for cancer patients....
Treatment · December 31, 2025
Key FDA Approvals of 2025 Signal Major Shifts in Patient Treatment
Top FDA approvals of 2025 highlight significant advances in pharmaceutical innovation and patient care....
Cancer · December 15, 2025
New Cancer Drugs Approved in 2025 After Pivotal Clinical Trial Results
Multiple new cancer drugs approved in 2025 from leading cancer research institution offer patients new hope....
Cancer · December 11, 2025
FDA Expands Bladder Cancer Drug Approval to Earlier Treatment Stages
Bladder cancer therapy expands FDA approval, bringing treatment access to more patients....
Pediatrics · December 5, 2025
FDA Approves Spinal Canal Delivery Method for SMA Gene Therapy
FDA approves innovative new delivery method for spinal muscular atrophy gene therapy, improving accessibility for patients....
Breakthrough · December 2, 2025
FDA Grants Priority Review to New Hypertension Drug for Treatment-Resistant Cases
Baxdrostat receives FDA priority review as a promising new option for patients struggling to control hypertension....
Breakthrough · August 18, 2025
FDA Grants Orphan Drug Status for Promising Behçet's Disease Treatment
Soligenix receives orphan drug designation for Behçet's disease treatment, offering hope to patients with this rare condition....